Form N-CSRS - Certified Shareholder Report, Semi-Annual:
SEC Accession No. 0001104659-20-070287
Filing Date
2020-06-05
Accepted
2020-06-05 16:02:20
Documents
12
Period of Report
2020-03-31
Effectiveness Date
2020-06-05

Document Format Files

Seq Description Document Type Size
1 N-CSRS tm2017901-1_ncsrs.htm N-CSRS 963994
2 EXHIBIT 99.CERT tm2017901d1_ex99cert.htm EX-99.CERT 19749
3 EXHIBIT 99.SECTION19(A) tm2017901d1_ex99section19a.htm EX-99.SECTION19(A) 39390
4 EXHIBIT 99.906 CERT tm2017901d1_ex99-906cert.htm EX-99.906 CERT 4352
5 GRAPHIC j20179012_aa001.jpg GRAPHIC 10616
6 GRAPHIC j20179012_aa002.jpg GRAPHIC 10881
7 GRAPHIC j20179012_aa003.jpg GRAPHIC 12929
8 GRAPHIC j20179012_ba004.jpg GRAPHIC 8151
9 GRAPHIC j20179012_ba005.jpg GRAPHIC 11338
10 GRAPHIC j20179012_ba006.jpg GRAPHIC 18235
11 GRAPHIC j20179012_ba007.jpg GRAPHIC 22712
12 GRAPHIC j20179012_ba008.jpg GRAPHIC 25704
  Complete submission text file 0001104659-20-070287.txt   1195805
Mailing Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110
Business Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110 6177728515
TEKLA LIFE SCIENCES INVESTORS (Filer) CIK: 0000884121 (see all company filings)

EIN.: 043147016 | State of Incorp.: MA | Fiscal Year End: 0930
Type: N-CSRS | Act: 40 | File No.: 811-06565 | Film No.: 20946108